Topics

FDA OKs Mepolizumab for Younger Children With Severe Asthma

12:18 EDT 12 Sep 2019 | Medscape

Nucala is the first biologic approved in the US for children aged 6 to 11 years with severe eosinophilic asthma.
News Alerts

Original Article: FDA OKs Mepolizumab for Younger Children With Severe Asthma

NEXT ARTICLE

More From BioPortfolio on "FDA OKs Mepolizumab for Younger Children With Severe Asthma"

Quick Search

Relevant Topic

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...